Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc ions (Zn²⁺) are essential trace elements involved in numerous biological processes. Chelation refers to the binding of zinc ions by molecules (chelators) that form stable complexes, modulating its bioavailability and activity. Chelators like CaEDTA, tricine, and ZX1 are used to study and manipulate zinc levels, particularly in neuroscience to understand its role in neurotransmission and synaptic function. Dysregulation of zinc is implicated in various diseases, making chelation a potential therapeutic strategy, but careful consideration of selectivity and safety is crucial.
Chelation of zinc ions, modulating their bioavailability and activity. This can involve antagonism of NMDA receptors and altering synaptic transmission.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc Ion (Chelation) (Zn²⁺ Chelation).